{[1-(methoxymethyl)cyclopropyl]methyl}amine hydrochloride → HCID 71715224, compound

HRID 575160Notes

Reaction equation

HRID 575160 reaction equation
[C:1]([C:4]1[N:5]=[C:6]2[C:12]3[CH:13]=[C:14]([C:18]#[C:19][C:20]([OH:23])([CH3:22])[CH3:21])[C:15]([F:17])=[CH:16][C:11]=3[O:10][CH2:9][CH2:8][N:7]2[C:24]=1[C:25](O)=[O:26])(=[O:3])[NH2:2].Cl.[CH3:29][O:30][CH2:31][C:32]1([CH2:35][NH2:36])[CH2:34][CH2:33]1>>[F:17][C:15]1[C:14]([C:18]#[C:19][C:20]([OH:23])([CH3:22])[CH3:21])=[CH:13][C:12]2[C:6]3[N:7]([C:24]([C:25]([NH:36][CH2:35][C:32]4([CH2:31][O:30][CH3:29])[CH2:34][CH2:33]4)=[O:26])=[C:4]([C:1]([NH2:2])=[O:3])[N:5]=3)[CH2:8][CH2:9][O:10][C:11]=2[CH:16]=1

Participants

3

Reactant 2

HCID 53398976{[1-(methoxymethyl)cyclopropyl]methyl}amine hydrochlorideHCID 866931712-Carbamoyl-9-fluoro-10-(3-hydroxy-3-methyl-but-1-ynyl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine-3-carboxylic acid

Product 1

HCID 71715224HCID 71715224, compound

Procedure

2-Carbamoyl-9-fluoro-10-(3-hydroxy-3-methyl-but-1-ynyl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine-3-carboxylic acid (0.05 g) was reacted with 1-[1-(methoxymethyl)cyclopropyl]methanamine monohydrochloride similar to as described in Example 2 to afford 11 mg of 9-fluoro-10-(3-hydroxy-3-methyl-but-1-ynyl)-N3-[[1-(methoxymethyl)cyclopropyl]methyl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine-2,3-dicarboxamide following reverse phase hplc purification. MS (Q1) 471 (M)+. 1H NMR (400 MHz, DMSO) δ 11.34 (t, J=5.3 Hz, 1H), 8.60 (d, J=8.4 Hz, 1H), 8.38 (s, 1H), 7.90 (s, 1H), 7.01 (d, J=10.6 Hz, 1H), 5.48 (s, 1H), 5.09-4.88 (m, 2H), 4.67-4.44 (m, 2H), 3.25 (s, 4H), 1.49 (s, 5H), 0.63-0.30 (m, 4H).

Sources & evidence

ORD record
ord-3738b8d586d44a70b1304cba1e1c7cf3
Source dataset
uspto-grants-2015_05
Patent number
US09034866B2

Reaction notes

Loading…